Skip to main content
Clinical Trials/ACTRN12620000553976
ACTRN12620000553976
Not yet recruiting
未知

Prevention of harmfull effect of hyperoxia with new monitorization method : ORI (oxygen reserve index )

Marmara University Medical Faculty0 sites20 target enrollmentMay 11, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
skull bone malformation
Sponsor
Marmara University Medical Faculty
Enrollment
20
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 11, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Marmara University Medical Faculty

Eligibility Criteria

Inclusion Criteria

  • 20 children who will undergo craniocinocytosis surgery, ASA I\-II, 2\-24 months of age and written informed consent from their families or legal officers will be included in the study.

Exclusion Criteria

  • Children with congenital or traumatic extremity pathology, with a history of allergy to the sensor material and body weight of less than 3 kg, patients with rectal abnormalities, thus contraindicated for rectal temperature probe placement, patients undergoing emergency surgery, or known heart failure or hypertension children with cardiac or vascular disease will be excluded from the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials